← Eichor
Study identifier: NCT05284552 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer

Condition: Epithelial Ovarian Cancer  ·  Sponsor: University Hospital, Linkoeping

PhasePhase 2
Planned participants40
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

Background: Previous findings have indicated antineoplastic properties of tinzaparin (Innohep®), a commonly used anti-coagulant. Earlier studies have mainly investigated the antineoplastic effects of tinzaparin in animal models and in human cell-lines. In this pilot study the aim is to examine the potential antitumoral effects of tinzaparin in vivo in women with epithelial ovarian cancer (EOC). Study objectives: Primary objective: The primary objective of the study is to evaluate the effects of tinzaparin on changes in levels of CA-125 in EOC patients who receive neoadjuvant chemotherapy (NACT). Secondary objectives: The secondary objective of the study is to explore the impact of tinzaparin on the dynamic of a spectrum of immunological and coagulation factors in EOC patients who receive NACT. Besides, the compliance of tinzaparin injections and adverse events caused by tinzaparin will be described.

This description comes directly from the study's public registry record.

Talk to the study team

Preben Kjölhede, MD, PhD  ·  +46101030000  ·  preben.kjolhede@regionostergotland.se

Anna Karlsson, MD  ·  +46101030000  ·  anna.br.karlsson@regionostergotland.se

Always discuss trial participation with your own doctor first.

Locations (8)

Department of Obstetrics and Gynecology, Highland HospitalEksjö, Eksjö, SwedenRecruiting
Department of Oncology, Sahlgrenska University HospitalGothenburg, Gothenburg, SwedenRecruiting
Department of Obstetrics and Gynecology, Ryhov County HospitalJönköping, Jönköping County, SwedenRecruiting
Department of Oncology, Linköping University HospitalLinköping, Linköping, SwedenRecruiting
Department of Obstetrics and Gynaecology, Norrland University HospitalUmeå, Umeå, SwedenRecruiting
Department of Obstetrics and Gynecology, Värnamo HospitalVärnamo, Värnamo, SwedenRecruiting
Department of Obstetrics and Gynecology, Västervik HospitalVästervik, Västervik, SwedenRecruiting
Department of Obstetrics and Gynecology, University HospitalLinköping, Östergötland County, SwedenActive Not Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05284552